vTv Therapeutics Inc.

About vTv Therapeutics Inc.

vTv Therapeutics is a clinical stage biopharmaceutical company dedicated to improving the lives of patients with diabetes. The company focuses on developing oral, small molecule drug candidates for various indications, including type 1 and type 2 diabetes, as well as other chronic conditions.

Products & Services

Cadisegliatin:A potential adjunctive therapy to insulin for the treatment of type 1 diabetes.

TTP399:A drug candidate in the pipeline, specific details not provided in the content.

Specialties

Oral small molecule drug development Diabetes treatment (Type 1 and Type 2) Chronic condition therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: PIPE T: - FT: PIPE	A: 80000000 MR: - FA: $80 million FAN: 80000000	D: 2025-09-02 FD: 2025-09-02	4 investors
2	RT: Private Placement T: - FT: Private Placement	A: 80000000 MR: - FA: $80 million FAN: 80000000	D: 2025-09-02 FD: 2025-09-02	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 51000000 MR: - FA: $51 million FAN: 51000000	D: 2024-02-28 FD: 2024-02-28	3 investors

PIPE Latest

2025-09-02

$80.0M

4 investors (Pro only)

Private Placement 2025-09-02

$80.0M

Private Placement 2024-02-28

$51.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Paul Sekhri

Chairman of the Board, President and Chief Executive Officer

F

Fahed Al Marzooqi

Director

S

Srinivas Akkaraju

Director

R

Raymond Cheong

Lead Independent Director

A

Anne Phillips

Director

D

Daniel K. Spiegelman

Director

View 7 more team members with Pro

Unlock Full Team Directory

Recent News